Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients.

ABSTRACT: Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.

SUBMITTER: Kim MK 

PROVIDER: S-EPMC8169368 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature